Hester Biosciences Limited has informed the Exchange regarding a press release dated December 28, 2022, titled "20221228 Press Release on Hester acquires technology from ICAR - NIHSAD to develop a Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry".